Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain
10.1038/sj.gt.3302011
Crossref journal-article
Springer Science and Business Media LLC
Gene Therapy (297)
Bibliography

Wang, C., Wang, C.-M., Clark, K. R., & Sferra, T. J. (2003). Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain. Gene Therapy, 10(17), 1528–1534.

Authors 4
  1. C Wang (first)
  2. C-M Wang (additional)
  3. K R Clark (additional)
  4. T J Sferra (additional)
References 40 Referenced 106
  1. Kaplitt MG et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet 1994; 8: 148–154. (10.1038/ng1094-148) / Nat Genet by MG Kaplitt (1994)
  2. McCown TJ et al. Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector. Brain Res 1996; 713: 99–107. (10.1016/0006-8993(95)01488-8) / Brain Res by TJ McCown (1996)
  3. Lo WD et al. Adeno-associated virus-mediated gene transfer to the brain: duration and modulation of expression. Hum Gene Ther 1999; 10: 201–213. (10.1089/10430349950018995) / Hum Gene Ther by WD Lo (1999)
  4. Clark KR et al. Gene transfer into the CNS using recombinant adeno-associated virus: analysis of vector DNA forms resulting in sustained expression. J Drug Target 1999; 7: 269–283. (10.3109/10611869909085510) / J Drug Target by KR Clark (1999)
  5. Mandel RJ et al. Midbrain injection of recombinant adeno-associated virus encoding rat glial cell line-derived neurotrophic factor protects nigral neurons in a progressive 6-hydroxydopamine-induced degeneration model of Parkinson's disease in rats. Proc Natl Acad Sci USA 1997; 94: 14083–14088. (10.1073/pnas.94.25.14083) / Proc Natl Acad Sci USA by RJ Mandel (1997)
  6. Fan DS et al. Behavioral recovery in 6-hydroxydompamine-lesioned rats by cotransduction of striatum with tyrosine hydroxylase and aromatic L-amino acid decarboxylase genes using two separate adeno-associated virus vectors. Hum Gene Ther 1998; 9: 2527–2535. (10.1089/hum.1998.9.17-2527) / Hum Gene Ther by DS Fan (1998)
  7. Skorupa AF et al. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice. Exp Neurol 1999; 160: 17–27. (10.1006/exnr.1999.7176) / Exp Neurol by AF Skorupa (1999)
  8. Klein RL et al. Long-term actions of vector-derived nerve growth factor or brain-derived neurotrophic factor on choline acetyltransferase and Trk receptor levels in the adult rat basal forebrain. Neuroscience 1999; 90: 815–821. (10.1016/S0306-4522(98)00537-5) / Neuroscience by RL Klein (1999)
  9. Sferra TJ et al. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse. Hum Gene Ther 2000; 11: 507–519. (10.1089/10430340050015707) / Hum Gene Ther by TJ Sferra (2000)
  10. Mastakov MY et al. Combined injection of rAAV with mannitol enhances gene expression in the rat brain. Mol Ther 2001; 3: 225–232. (10.1006/mthe.2001.0246) / Mol Ther by MY Mastakov (2001)
  11. During MJ et al. In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector. Gene Ther 1998; 5: 820–827. (10.1038/sj.gt.3300650) / Gene Ther by MJ During (1998)
  12. Bartlett JS, Samulski RJ, McCown TJ . Selective and rapid uptake of adeno-associated virus type 2 in brain. Hum Gene Ther 1998; 9: 1181–1186. (10.1089/hum.1998.9.8-1181) / Hum Gene Ther by JS Bartlett (1998)
  13. Hamilton JF et al. Heparin coinfusion during convection-enhanced delivery (CED) increases the distribution of the glial-derived neurotrophic factor (GDNF) ligand family in rat striatum and enhances the pharmacological activity of neurturin. Exp Neurol 2001; 168: 155–161. (10.1006/exnr.2000.7571) / Exp Neurol by JF Hamilton (2001)
  14. Nguyen JB et al. Convection-enhanced delivery of AAV-2 combined with heparin increases TK gene transfer in the rat brain. Neuroreport 2001; 12: 1961–1964. (10.1097/00001756-200107030-00037) / Neuroreport by JB Nguyen (2001)
  15. Mastakov MY et al. Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain. J Virol 2002; 76: 8446–8454. (10.1128/JVI.76.16.8446-8454.2002) / J Virol by MY Mastakov (2002)
  16. Girod A et al. Genetic capsid modifications allow efficient re-targeting of adeno- associated virus type 2. Nat Med 1999; 5: 1052–1056. (10.1038/12491) / Nat Med by A Girod (1999)
  17. Wu P et al. Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol 2000; 74: 8635–8647. (10.1128/JVI.74.18.8635-8647.2000) / J Virol by P Wu (2000)
  18. Shi W, Arnold GS, Bartlett JS . Insertional mutagenesis of the adeno-associated virus type 2 (AAV2) capsid gene and generation of AAV2 vectors targeted to alternative cell- surface receptors. Hum Gene Ther 2001; 12: 1697–1711. (10.1089/104303401750476212) / Hum Gene Ther by W Shi (2001)
  19. Bartlett JS et al. Targeted adeno-associated virus vector transduction of nonpermissive cells mediated by a bispecific F(ab'gamma)2 antibody. Nat Biotechnol 1999; 17: 181–186. (10.1038/6185) / Nat Biotechnol by JS Bartlett (1999)
  20. Chiorini JA et al. Cloning of adeno-associated virus type 4 (AAV4) and generation of recombinant AAV4 particles. J Virol 1997; 71: 6823–6833. (10.1128/jvi.71.9.6823-6833.1997) / J Virol by JA Chiorini (1997)
  21. Rutledge EA, Halbert CL, Russell DW . Infectious clones and vectors derived from adeno-associated virus (AAV) serotypes other than AAV type 2. J Virol 1998; 72: 309–319. (10.1128/JVI.72.1.309-319.1998) / J Virol by EA Rutledge (1998)
  22. Chiorini JA et al. Cloning and characterization of adeno-associated virus type 5. J Virol 1999; 73: 1309–1319. (10.1128/JVI.73.2.1309-1319.1999) / J Virol by JA Chiorini (1999)
  23. Xiao W et al. Gene therapy vectors based on adeno-associated virus type 1. J Virol 1999; 73: 3994–4003. (10.1128/JVI.73.5.3994-4003.1999) / J Virol by W Xiao (1999)
  24. Rabinowitz JE et al. Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J Virol 2002; 76: 791–801. (10.1128/JVI.76.2.791-801.2002) / J Virol by JE Rabinowitz (2002)
  25. Gao G-P et al. Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854–11859. (10.1073/pnas.182412299) / Proc Natl Acad Sci USA by G-P Gao (2002)
  26. Chao H et al. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2: 619–623. (10.1006/mthe.2000.0219) / Mol Ther by H Chao (2000)
  27. Davidson BL et al. Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system. Proc Natl Acad Sci USA 2000; 97: 3428–3432. (10.1073/pnas.97.7.3428) / Proc Natl Acad Sci USA by BL Davidson (2000)
  28. Auricchio A et al. Exchange of surface proteins impacts on viral vector cellular specificity and transduction characteristics: the retina as a model. Hum Mol Genet 2001; 10: 3075–3081. (10.1093/hmg/10.26.3075) / Hum Mol Genet by A Auricchio (2001)
  29. Summerford C, Samulski RJ . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J Virol 1998; 72: 1438–1445. (10.1128/JVI.72.2.1438-1445.1998) / J Virol by C Summerford (1998)
  30. Kaludov N et al. Adeno-associated virus serotype 4 (AAV4) and AAV5 both require sialic acid binding for hemagglutination and efficient transduction but differ in sialic acid linkage specificity. J Virol 2001; 75: 6884–6893. (10.1128/JVI.75.15.6884-6893.2001) / J Virol by N Kaludov (2001)
  31. Walters RW et al. Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J Biol Chem 2001; 276: 20610–20616. (10.1074/jbc.M101559200) / J Biol Chem by RW Walters (2001)
  32. Clark KR et al. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses. Hum Gene Ther 1999; 10: 1031–1039. (10.1089/10430349950018427) / Hum Gene Ther by KR Clark (1999)
  33. Klein RL et al. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp Neurol 1998; 150: 183–194. (10.1006/exnr.1997.6736) / Exp Neurol by RL Klein (1998)
  34. Passini MA et al. Distribution of a lysosomal enzyme in the adult brain by axonal transport and by cells of the rostral migratory stream. J Neurosci 2002; 22: 6437–6446. (10.1523/JNEUROSCI.22-15-06437.2002) / J Neurosci by MA Passini (2002)
  35. Alvarez-Buylla A, Seri B, Doetsch F . Identification of neural stem cells in the adult vertebrate brain. Brain Res Bull 2002; 57: 751–758. (10.1016/S0361-9230(01)00770-5) / Brain Res Bull by A Alvarez-Buylla (2002)
  36. Chen H et al. Oligodendrocyte-specific gene expression in mouse brain: use of a myelin-forming cell type-specific promoter in an adeno-associated virus. J Neurosci Res 1999; 55: 504–513. (10.1002/(SICI)1097-4547(19990215)55:4<504::AID-JNR10>3.0.CO;2-0) / J Neurosci Res by H Chen (1999)
  37. Clark KR et al. Cell lines for the production of recombinant adeno-associated virus. Hum Gene Ther 1995; 6: 1329–1341. (10.1089/hum.1995.6.10-1329) / Hum Gene Ther by KR Clark (1995)
  38. Samulski RJ, Chang L-S, Shenk T . A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication. J Virol 1987; 61: 3097–3101. (10.1128/jvi.61.10.3096-3101.1987) / J Virol by RJ Samulski (1987)
  39. Zolotukhin S et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Therapy 1999; 6: 973–985. (10.1038/sj.gt.3300938) / Gene Therapy by S Zolotukhin (1999)
  40. Franklin KBJ, Paxinos G . The Mouse Brain in Stereotaxic Coordinates. Academic Press: San Diego, 1997. / The Mouse Brain in Stereotaxic Coordinates by KBJ Franklin (1997)
Dates
Type When
Created 22 years, 1 month ago (Aug. 4, 2003, 11:15 a.m.)
Deposited 3 years, 5 months ago (March 29, 2022, 10:37 p.m.)
Indexed 1 month, 1 week ago (July 25, 2025, 6:31 a.m.)
Issued 22 years, 1 month ago (Aug. 1, 2003)
Published 22 years, 1 month ago (Aug. 1, 2003)
Published Online 22 years, 1 month ago (Aug. 4, 2003)
Published Print 22 years, 1 month ago (Aug. 1, 2003)
Funders 0

None

@article{Wang_2003, title={Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain}, volume={10}, ISSN={1476-5462}, url={http://dx.doi.org/10.1038/sj.gt.3302011}, DOI={10.1038/sj.gt.3302011}, number={17}, journal={Gene Therapy}, publisher={Springer Science and Business Media LLC}, author={Wang, C and Wang, C-M and Clark, K R and Sferra, T J}, year={2003}, month=aug, pages={1528–1534} }